Keywords: anadys, selects, ana975, hepatitis, usa, pharmaceuticals, selected

Anadys selects ANA975 for hepatitis C

Article | 07 June 2004

The USA's Anadys Pharmaceuticals has selected ANA975, an oral prodrug of isatoribine (ANA245; Marketletter March 10, 2003), as its development candidate for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Nystatin

Go to drug listing